| Original language | English (US) |
|---|---|
| Pages (from-to) | 1105-1106 |
| Number of pages | 2 |
| Journal | JAMA - Journal of the American Medical Association |
| Volume | 322 |
| Issue number | 11 |
| DOIs | |
| State | Published - Sep 17 2019 |
ASJC Scopus subject areas
- Medicine(all)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In reply. / Packer, Douglas L.; Mark, Daniel B.; Lee, Kerry L.
In: JAMA - Journal of the American Medical Association, Vol. 322, No. 11, 17.09.2019, p. 1105-1106.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - In reply
AU - Packer, Douglas L.
AU - Mark, Daniel B.
AU - Lee, Kerry L.
N1 - Funding Information: Corresponding Author: Douglas L. Packer, MD, Mayo Clinic Hospital–St Mary’s Campus, 1216 2nd St SW, Al 2-416, Rochester, MN 55902 (packer@mayo.edu). Conflict of Interest Disclosures: Dr Packer reported receiving grants from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI), St Jude Medical Corporation and Foundation, Biosense Webster Inc, Medtronic Inc, Boston Scientific Corp, Abbott, CardioFocus, CardioInsight, Siemens, Thermedical, Endosense, Robertson Foundation, and Hansen Medical; serving on the advisory board without compensation for Abbott, Biosense Webster Inc, Boston Scientific Corp, CardioFocus, Medtronic Inc, St Jude Medical, Spectrum Dynamics, Siemens, Thermedical, Johnson & Johnson, and SigNum Preemptive Healthcare Inc; speaking with honorarium from Biotronik and MediaSphere Medical LLC; and receiving royalties from Wiley & Sons, Oxford, and St Jude Medical. Dr Packer and Mayo Clinic jointly have equity in a privately held company, External Beam Ablation Medical Devices. Dr Packer also has mapping technologies with royalties paid. Dr Mark reported receiving grants from the NIH/NHLBI, Mayo Clinic, Merck, Oxygen Therapeutics, Bristol-Myers Squibb, AstraZeneca, the University of Calgary, Eli Lilly & Company, AGA Medical, St Jude Medical, and Tufts University and personal fees from CeleCor. Dr Lee reported receiving grants from the NIH/NHLBI, Mayo Clinic, St Jude Medical Foundation and Corporation, Biosense Webster Inc, Medtronic Inc, and Boston Scientific Corp and serving on data and safety monitoring boards on studies funded by AstraZeneca, Medtronic Inc, Merck, Amgen, and the Cardiovascular Research Foundation. 1. Packer DL, Mark DB, Robb RA, et al; CABANA Investigators. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321(13):1261-1274. doi:10.1001/jama.2019.0693 Funding Information: Conflict of Interest Disclosures: Dr Wang reported serving as a consultant for Abbott and a research investigator for Boston Scientific, and receiving fellowship support from Abbott and Medtronic.
PY - 2019/9/17
Y1 - 2019/9/17
UR - http://www.scopus.com/inward/record.url?scp=85072297855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072297855&partnerID=8YFLogxK
U2 - 10.1001/jama.2019.10688
DO - 10.1001/jama.2019.10688
M3 - Letter
C2 - 31529005
AN - SCOPUS:85072297855
VL - 322
SP - 1105
EP - 1106
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0002-9955
IS - 11
ER -